小结
定义
病史和体格检查
关键诊断因素
- history of Helicobacter pylori gastritis
- history of autoimmune disorder
- age >60 years
- dyspepsia
- epigastric discomfort
- skin lesions
- red eye ± photophobia
- conjunctival fornix mass
- painless proptosis, motility disturbances of the eye, diplopia, ptosis, decreased vision
其他诊断因素
- abdominal pain, nausea, diarrhea, malabsorption, vomiting
- GI bleeding, perforation, and obstruction
- fever
- night sweats
- weight loss
- shortness of breath, hemoptysis, cough
- salivary gland swelling
- thyroid swelling
- esophageal/tracheal obstruction (shortness of breath, dysphagia, tracheal deviation)
- breast lump
- focal neurologic deficits
- lymphadenopathy
危险因素
- Helicobacter pylori infection
- age >60 years
- autoimmune disease
- Chlamydia psittaci infection
- Campylobacter jejuni infection
- Borrelia burgdorferi infection
- hepatitis C virus infection
- hepatitis B virus infection
- HIV infection
- achromobacter xylosoxidans infection
诊断性检查
首要检查
- CBC with differential
- blood smear
- comprehensive metabolic panel (including LFTs)
- serum lactate dehydrogenase (LDH)
- serum beta-2 microglobulin
- upper GI endoscopy
- tissue biopsy of affected site
- immunophenotyping
- H pylori (histologic testing)
- CT scan
需考虑的检查
- H pylori (stool antigen test)
- H pylori (urea breath test)
- H pylori (serology test)
- PCR testing for infectious agents
- bone marrow biopsy with aspirate
- genetic studies
- immunoglobulin gene rearrangement studies
- MYD88 mutation testing
- serum protein electrophoresis
- 18F-fluorodeoxyglucose (FDG) PET/CT scan
- endoscopic ultrasound of the stomach
- lower GI endoscopy
- MRI orbit, brain
- mammography
- breast ultrasound
- MRI breast
- thyroid ultrasound
- bronchoscopy
- hepatitis C serology
- hepatitis B serology
- HIV serology
- multigated acquisition (MUGA) scan
- echocardiography
治疗流程
localized gastric MALT lymphoma: Helicobacter pylori-positive and t(11;18)-negative (or unknown)
localized gastric MALT lymphoma: Helicobacter pylori-negative, or Helicobacter pylori-positive and t(11;18)-positive
advanced gastric MALT lymphoma
localized nongastric MALT lymphoma
advanced nongastric MALT lymphoma
high-grade histologic transformation
撰稿人
作者
Christopher McNamara, MBBS (Hons), FRACP, FRCPA, FRCPath
Consultant Haematologist
Royal Free Hospital
London
UK
Declarações
CM declares that he has no competing interests.
Agradecimentos
Dr Christopher McNamara wishes to gratefully acknowledge Dr Rahul Joshi, a previous contributor to this topic. RJ declared that he had no competing interests. Unfortunately, we have since been made aware that Dr Rahul Joshi is deceased.
Revisores
Markus Raderer, MD
Professor of Medicine
Department of Internal Medicine I
Division of Oncology
Medical University Vienna
Austria
Declarações
MR is an author of a number of references cited in this topic.
Alan Lichtin, MD
Staff Hematologist
Cleveland Clinic Taussig Cancer Center
Cleveland
OH
Declarações
AL declares that he has no competing interests.
Ian Chau, MD
Consultant Medical Oncologist
Royal Marsden Hospital
Sutton
UK
Declarações
IC has been reimbursed by Roche Products, the manufacturer of rituximab, for attending several conferences. IC has also served on advisory boards and received honorarium for giving presentations for Roche Products. IC has received research funding from Novartis to conduct academic studies in the treatment of colorectal cancer.
Créditos aos pareceristas
Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.
Declarações
As afiliações e declarações dos pareceristas referem--se ao momento da revisão.
Referências
Principais artigos
Walewska R, Eyre TA, Barrington S, et al. Guideline for the diagnosis and management of marginal zone lymphomas: a British Society of Haematology guideline. Br J Haematol. 2024 Jan;204(1):86-107.Texto completo Resumo
National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: B-cell lymphomas [internet publication].Texto completo
Eyre TA, Cwynarski K, d'Amore F, et al. Lymphomas: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol. 2025 Nov;36(11):1263-84.Texto completo Resumo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.

Diagnósticos diferenciais
- Mantle cell lymphoma
- Chronic lymphocytic leukemia/small lymphocytic lymphoma
- Follicular lymphoma
Mais Diagnósticos diferenciaisDiretrizes
- NCCN clinical practice guidelines in oncology: B-cell lymphomas
- Lymphomas: ESMO clinical practice guideline for diagnosis, treatment and follow-up
Mais DiretrizesFolhetos informativos para os pacientes
Non-Hodgkin lymphoma
Mais Folhetos informativos para os pacientesConectar-se ou assinar para acessar todo o BMJ Best Practice
O uso deste conteúdo está sujeito ao nosso aviso legal
